VEGFR2 activation mediates the pro-angiogenic activity of BMP4

Angiogenesis. 2019 Nov;22(4):521-533. doi: 10.1007/s10456-019-09676-y. Epub 2019 Jul 30.

Abstract

The Bone Morphogenetic Protein 4 (BMP4) regulates multiple biological processes, including vascular development and angiogenesis. Here, we investigated the role of Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) in mediating the angiogenic activity of BMP4. BMP4 induces a rapid relocation and phosphorylation of VEGFR2 on the endothelial cell membrane. These effects occur in the absence of a direct interaction of BMP4 and/or BMP receptors with VEGFR2. At variance, BMP4, by interacting with the BMPRI-II hetero-complex, induces c-Src phosphorylation which, in turn, activates VEGFR2, leading to an angiogenic response. Accordingly, the BMPR inhibitor dorsomorphin prevents c-Src activation and specific inhibition of c-Src significantly reduces downstream VEGFR2 phosphorylation and the angiogenic activity exerted by BMP4 in a chick embryo chorioallantoic membrane assay. Together, our data indicate that the pro-angiogenic activity exerted by BMP4 in endothelial cells is mediated by a BMPR-mediated intracellular transactivation of VEGFR2 via c-Src.

Keywords: Angiogenesis; BMP4; VEGFR2; c-Src.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Morphogenetic Protein 4 / metabolism*
  • CSK Tyrosine-Protein Kinase / metabolism
  • Cattle
  • Chick Embryo
  • Humans
  • Neovascularization, Physiologic*
  • Signal Transduction*
  • Transcriptional Activation
  • Vascular Endothelial Growth Factor Receptor-2 / metabolism*

Substances

  • BMP4 protein, human
  • Bone Morphogenetic Protein 4
  • KDR protein, human
  • Vascular Endothelial Growth Factor Receptor-2
  • CSK Tyrosine-Protein Kinase
  • CSK protein, human